Radiosensitizing Effect of Irinotecan and Oxaliplatin alone and in Combination with 5-Fluorouracil on human colorectal Tumor Cells

被引：0
|
作者：
Frerker, Bernd [1 ]
Bock, Felix [1 ]
Cappel, Marie-Louise [2 ]
Klautke, Gunther [3 ]
Hildebrandt, Guido [1 ]
Manda, Katrin [1 ]
机构：
[1] Univ Med Rostock, Klin & Poliklin Strahlentherapie, Rostock, Germany
[2] CSL Plasma GmbH, Marburg, Germany
[3] Klinikum Chemnitz gGmbH, Klin Radioonkol, Chemnitz, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2023年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P03-7-jD
引用
收藏
页码：S72 / S72
页数：1
相关论文
共 50 条
  • [31] Gap junction composed of connexin43 modulates 5-fluorouracil, oxaliplatin and irinotecan resistance on colorectal cancers
    Zou, Zhao-Wei
    Chen, Hai-Jin
    Yu, Jin-Long
    Huang, Zong-Hai
    Fang, Shun
    Lin, Xiao-Hua
    [J]. MOLECULAR MEDICINE REPORTS, 2016, 14 (05) : 4893 - 4900
  • [32] Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-fluorouracil and infusional 5-fluorouracil alone in advanced pancreatic carcinoma patients -: Response
    Ducreux, M
    Mitry, E
    Ould-Kaci, A
    Boige, V
    Seitz, JF
    Bugat, R
    Breau, JL
    Bouché, O
    Etienne, PL
    Tigaud, JM
    Morvan, F
    Cvitkovic, E
    Rougier, P
    [J]. ANNALS OF ONCOLOGY, 2004, 15 (10) : 1577 - 1578
  • [33] Biweekly cetuximab and irinotecan as third-line therapy in patients with advanced colorectal cancer after failure to irinotecan, oxaliplatin and 5-fluorouracil
    Pfeiffer, P.
    Nielsen, D.
    Bjerregaard, J.
    Qvortrup, C.
    Yilmaz, M.
    Jensen, B.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (06) : 1141 - 1145
  • [34] Bevacizumab plus infusional 5-fluorouracil, leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy: A pilot study
    Kwon, Hyuk-Chan
    Oh, Sung Yong
    Lee, Suee
    Kim, Sung-Hyun
    Kim, Hyo-Jin
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (46) : 6231 - 6235
  • [35] POTENTIATION OF 5-FLUOROURACIL EFFECT WITH ETHYLDEOXYURIDINE PRETREATMENT (EDURD) IN HUMAN COLORECTAL TUMOR XENOGRAFTS
    LAPIS, K
    KOPPER, L
    JENEY, A
    MAGYAROSY, E
    SZABOLCS, A
    OTVOS, L
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 263 - 263
  • [36] Bevacizumab plus infusional 5-fluorouracil,leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy:A pilot study
    Hyuk-Chan Kwon
    Sung Yong Oh
    Suee Lee
    Sung-Hyun Kim
    Hyo-Jin Kim
    [J]. World Journal of Gastroenterology, 2007, (46) : 6231 - 6235
  • [37] Chronotherapy with 5-fluorouracil, oxaliplatin, and folinic acid in colorectal cancer
    Sandor, V
    [J]. LANCET, 1997, 350 (9087): : 1325 - 1326
  • [38] Oxaliplatin combined with 5-fluorouracil and methotrexate in advanced colorectal cancer
    Zampino, MG
    Lorizzo, K
    Rocca, A
    Locatelli, M
    Zorzino, L
    Manzoni, S
    Mazzetta, C
    Fazio, N
    Biffi, R
    De Braud, F
    [J]. ANTICANCER RESEARCH, 2006, 26 (3B) : 2425 - 2428
  • [39] Multiorgan Failure in a Patient Treated With the 5-Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Regimen
    Schwartzman, Andrew D.
    Sethi, Roshan
    Smith, Roy
    [J]. CLINICAL COLORECTAL CANCER, 2013, 12 (02) : 136 - 139
  • [40] THROMBOGENICITY OF INTRAVENOUS 5-FLUOROURACIL ALONE OR IN COMBINATION WITH CISPLATIN
    KUZEL, T
    ESPARAZ, B
    GREEN, D
    KIES, M
    [J]. CANCER, 1990, 65 (04) : 885 - 889
12345